Prelude Therapeutics Company Profile

09:16 EDT 16th June 2019 | BioPortfolio

Prelude Therapeutics is a privately held, clinical-stage biopharmaceutical company based in Wilmington, DE. Prelude is focused on the discovery and development of small molecule agents targeting novel molecular mechanisms that drive cancer cell growth, survival and resistance to current treatments. For more information, please visit

News Articles [858 Associated News Articles listed on BioPortfolio]

Funding round pulls in $60M for Prelude

A round of Series B funding has raised $60 million for Prelude Therapeutics, which intends to use the proceeds to fund clinic -More- 

Series B round brings $60mm to Prelude Therapeutics

Prelude Therapeutics Inc. (developing cancer therapies targeting treatment resistance mechanisms) raised $60mm in its Series B round that was co-led by two returning backers including OrbiMed Advisors...

Prelude Therapeutics Rakes in $60 Million in Series B Funding, Expands Executive Team

The round brings total financing up to $95 million.

Prelude Therapeutics raises $60M in Series B round for solid tumor, blood cancer drug

The company is developing a PRMT5 inhibitor, currently in a Phase I study for lymphomas, myeloid malignancies and solid tumors.

Reproductive Biology Associates Announces Opening of New Location on the Campus of Piedmont Atlanta Hospital

ATLANTA (PRWEB) February 19, 2019 Reproductive Biology Associates (RBA), the oldest continuously operating full-service private fe...

Prelude Therapeutics Secures $60 Million and Expands Management Team to Develop Drugs Targeting Novel Molecular Mechanisms in Cancer

- Advances lead product into clinic and additional compounds into preclinical development - David Mauro, MD, PhD, as Chief Medical Officer, and Brian Piper, MBA, a...

OrbiMed-backed Prelude raises $60M to take PRMT5 program through clinical POC

No fewer than six Democrats — including @SenWarren and @CoryBooker — have stepped up criticism of the drug industry over just the past month, a prelude to the 2020 presidential campaign. 

No fewer than six Democrats — including @SenWarren and @CoryBooker — have stepped up criticism of the drug industry over just the past month, a prelude to the 2020 presidential campaign....

Drugs and Medications [27 Associated Drugs and Medications listed on BioPortfolio]

Kynamro [kastle therapeutics, llc]


Olopatadine hydrochloride [somerset therapeutics, llc]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

Oxygen [breathe easy therapeutics, inc]


Diclofenac sodium delayed release [cambridge therapeutics technologies, llc]

Diclofenac Sodium

Olopatadine hydrochloride [a-s medication solutions]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

PubMed Articles [484 Associated PubMed Articles listed on BioPortfolio]

Global chemotherapy demands: a prelude to equal access.

The use of fast photochemical oxidation of proteins coupled with mass spectrometry in protein therapeutics discovery and development.

Structural analysis of protein therapeutics is a challenging task owing to complexities associated with large molecular size and 3D structures. Recent advances in fast photochemical oxidation of prote...

Biologics for the treatment of noninfectious uveitis: current concepts and emerging therapeutics.

There is mounting evidence supporting the use of biologic therapeutics for the management of noninfectious uveitis (NIU). This review highlights: biologics with documented efficacy in NIU; agents with...

CRISPR: a promising tool for lipid physiology and therapeutics.

The purpose is to review recent progress in applying the CRISPR/Cas9 system to lipid metabolism and therapeutics.

Bacterial magnetosomes-based nanocarriers for co-delivery of cancer therapeutics in vitro.

In recent times, co-delivery of therapeutics has emerged as a promising strategy for treating dreadful diseases such as cancer.

Clinical Trials [196 Associated Clinical Trials listed on BioPortfolio]

PRospective Study for TrEatment of Atherosclerotic Lesions in Infrapopliteal Arteries Using the Serranator® DevicE (PRELUDE)

The objective of the PRELUDE BTK study is to assess safety and efficacy of the Serranator® PTA Serration Balloon Catheter (study device) in subjects with atherosclerotic peripheral artery...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Companies [1343 Associated Companies listed on BioPortfolio]

Prelude Therapeutics

Prelude Therapeutics is a privately held, clinical-stage biopharmaceutical company based in Wilmington, DE. Prelude is focused on the discovery and development of small molecule a...

Prelude Ventures Ltd

Prelude is an independent venture capital company specialising in investments in seed, start-up and early stage businesses on the leading edge of new developments in the physical and life sciences and...

Prelude Fertility

Prelude was founded in 2016 with the singular mission of helping people ensure their best chances of having a healthy baby when they are ready. The company has become the fastest-...

Echo Therapeutics, Inc.

Echo is developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system for use in hospital critical care units and for patients with diabetes. Echo ...

Iceni BioDiscovery Limited

Iceni BioDiscovery Ltd is a product-focused biotechnology company that is developing commercial cell therapies for unmet medical needs. Iceni will initially target diabetes where recent success in tr...

More Information about "Prelude Therapeutics" on BioPortfolio

We have published hundreds of Prelude Therapeutics news stories on BioPortfolio along with dozens of Prelude Therapeutics Clinical Trials and PubMed Articles about Prelude Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Prelude Therapeutics Companies in our database. You can also find out about relevant Prelude Therapeutics Drugs and Medications on this site too.

Quick Search


Relevant Topic

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Corporate Database Quicklinks

Searches Linking to this Company Record